COVID-19 vaccine nearing end of Phase III trials!
SinoVac is developing one of the world’s first and safest COVID-19 vaccines. Nearly 70,000 people worldwide have been vaccinated with CoronaVac™ with minimal side effects. EUAs have been granted in over 5 countries with more on the way soon.
Due to our special relationship with SinoVac, Amigo Health can facilitate priority access to place you among the first to receive the new COVID-19 vaccine as soon as it’s authorized in your country.
Contact Amigo Health for Details: info@Amigo-Health.com
Amigo Health US Headquarters: 253-732-1950